Skip to main content
Fig. 5 | Molecular Cancer

Fig. 5

From: Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo

Fig. 5

Orthotopic RCC tumor growth following treatment with anti-CAIX mAbs. (a) Tumor growth was determined in each treatment group by BLI, following injection of antibodies and human PBMC as described in Fig. 4. Data represent measurement of three mice and are representative of two independent experiments. * indicates p value of two-way ANOVA < 0.05, compared to control IgG. (b) Representative images of BLI measurement depicted in (a)

Back to article page